Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Gross Profit | 5,990 | 5,320 | 5,910 | 7,900 | 6,590 |
| Operating Expenses | 0 | 3,210 | 4,340 | 2,660 | 3,020 |
| Operating Income | N/A | -3,210 | -4,340 | -2,660 | -3,020 |
| Pre-tax Income | 0 | -3,210 | -4,340 | -2,660 | -3,020 |
| Net Income Continuous | N/A | -3,210 | -4,340 | -2,660 | -3,020 |
| Net Income | $N/A | $-3,210 | $-4,340 | $-2,660 | $-3,020 |
| EBITDA(a) | $1,070 | $-2,040 | $-2,790 | $-470 | $-1,130 |